Christer Borgfeldt
1 – 10 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples
- Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
- Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
- Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients – a comparative cohort study
- A Swedish population-based evaluation of benign hysterectomy, comparing minimally invasive and abdominal surgery
- 2017
- Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
- The economic burden of human papillomavirus-related precancers and cancers in Sweden
- Risk factors for lymph node metastases in women with endometrial cancer : A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group
- Postmenopausal hormone therapy and risk of stroke : A pooled analysis of data from population-based cohort studies
- Vaginal and urine self-sampling compared to cervical sampling for HPV-testing with the cobas 4800 HPV test